Financial Tearsheet

Company Overview

Recent Financial News

Date   Headline
Dec 06, 2018 Aytu BioScience Announces Commercial Availability of Tuzistra(R) XR (codeine polistirex and chlorpheniramine polistirex) oral suspension
Dec 04, 2018 Aytu BioScience Provides Webcast Information for 2018 LD Micro Conference Presentation
Dec 03, 2018 Aytu BioScience Announces Appointment of Two New Directors, Steven Boyd and Ketan Mehta
Nov 30, 2018 Aytu BioScience Announces Closing of $5M Investment from Armistice Capital
Nov 27, 2018 Aytu BioScience to Present at 11th Annual LD Micro Main Event Investor Conference on December 5, 2018

IR Contacts

Hayden IR

James Carbonara
1441 Broadway
Fifth Floor
New York, NY 10018
Office: (646)-755-7412
James@haydenir.com

Stock Performance

Today's Open 0.9300
Volume 84,900
Day Range 0.8700 - 0.9388
52 Week Range 0.2330 - 6.9600
Bid/Ask 0.8800 / 0.9000
Bid/Ask Size 100 X 400
Previous Close 0.9040
Market Cap 7.62 million
Shares Outstanding 8.63 million
Dividend/Yield 0.0000 / 0.0000%
EPS (TTM) -24.253400
P/E Ratio (TTM) N/A

Recent XBRL Filings

Filing Date Form Type Description View
Nov 07, 2018 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Sep 06, 2018 10-K Annual report htmlhtml   pdfpdf   xbrlxbrl  
May 14, 2018 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Feb 08, 2018 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Nov 09, 2017 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  

Management Team

Josh Disbrow, Chairman & Chief Executive Officer

Jarrett Disbrow, Chief Operating Officer

David Green, Chief Financial Officer

Board of Directors

Josh Disbrow, Chairman & Chief Executive Officer

Gary Cantrell, Director, Chair, Compensation Committee

Carl Dockery, Director, Chair, Nominating & Governance Committee

John Donofrio, Jr., Director, Chair, Audit Committee

Michael Macaluso, Director